Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia
NCT06890494
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
BiTE-EV
Sponsor
Beijing GoBroad Hospital